Microtome Market Latest Trends, Demand and Advancement 2027

According to our latest study on “Microtome Market Forecast to 2027- COVID-19 Impact and Global Analysis- by product, technology, and end user,” the market was valued at US$ 132.6 million in 2019 and is projected to reach US$ 204.3 million by 2027; it is expected to grow at a CAGR of 5.7% during 2020-2027. The report highlights trends prevailing in the global microtome market, and the drivers and hindrances pertaining to the market growth.

Microtome is a device used for sample preparation in laboratories. The devices are used to slice biological specimens into evenly thin sections for a detailed microscopic examination. The microtome market is expected to witness huge growth during the forecast period on the back of the rising prevalence of cancer and increasing adoption of digital pathology. Moreover, growing focus on personalized medicine is further expected to foster the market growth in the coming years. However, the lack of adoption of microtome in low-income countries limits the growth of the market.

Get sample Research Pages of Microtome Market study at: https://www.theinsightpartners.com/sample/TIPRE00006522/

Microtome Market Competitive Landscape and Key Development

The growth of the microtome market is attributed to factors such as rising prevalence of cancer and increasing adoption of digital pathology. However, the lack of adoption of microtomes in low-income countries restrains the growth of the market. PHC Holdings Corporation, MEDITE Medical GmbH, Sakura Finetek USA, Inc., Leica Biosystems Nussloch GmbH (Danaher), Histo-Line Laboratories, SLEE medical GmbH, Diapath S.p.A., Amos Scientific Pty Ltd, Boeckeler Instruments, Inc., and SM Scientific Instruments Pvt. Ltd are among the leading companies operating in the global microtome market.

Rising Prevalence of Cancer

Cancer is one of the leading causes of death worldwide, and its rising prevalence is increasing the number of histopathology tests.  A tissue pathology examination is required for the diagnosis of a malignant tumor to predict the onset of cancer. As per the WHO, an estimated 9.6 million deaths were caused by cancer in 2018. Increasing incidences of cancer and growing awareness regarding early diagnostic procedures are anticipated to boost the adoption rate of microtomes during the forecast period.

Analysis of biopsy tissues helps pathologists in determining cancer type, stage, and the degree of disease spread. Moreover, growing awareness programs undertaken by organizations such as National Cervical Cancer Coalition, World Health Organization (WHO), and the Centers for Disease Control and Prevention (CDC) for cancer screening is further driving the market growth. For instance, the National Health Service (NHS) offers cervical screening programs for all women between 25 and 64 years of age in the UK. Also, Cancer Council Australia has recommended mammography as screening tool for the early detection of breast cancer. The screening program-BreastScreen Australia-allows women aged 50-74 to get free mammograms in every two years. As per the BreastScreen Australia, over 1.8 million women aged 50-74 participated in the screening program in 2017-2018. Thus, the aforementioned factors have led to an increased adoption of histopathology and tissue sectioning instruments, in turn, propelling the market growth.

Microtome Market: Segmental Overview

Based on product, the microtome market is segmented into microtome instruments and microtome accessories. The microtome instruments segment held a larger share of the market in 2019. A microtome instrument precisely slices sections from a block of embedded tissue. A variety of microtomes are used to section paraffin-embedded tissues. Microtomes and cryostats cut uniform sections of tissues for research and diagnostic purposes. Advanced versions of microtomes can cut the sections of thickness ranging from 0.1 μm to 100 μm. These devices are available in various forms, such as rotating, freezing, sliding, ultra, and laser microtomes. Therefore, the availability of a wide range of microtomes for different applications in pathology is driving the segmental market growth.

Based on technology, the microtome market is segmented into manual microtomes, semi-automated microtomes, and fully automated microtomes. The fully automated microtomes segment held the largest share of the market in 2019 owing to growing demand for technologically advanced products, especially in developed economies. Additionally, the presence of commercially available fully automated systems and increasing preference for the digitalization of tissue diagnostic procedures are crucial factors boosting the growth of the market for this segment. A few of the automated products are Tissue-Tek Auto Section Automated Microtome and PT-PC Power Tomes. Further, the segment is anticipated to register the highest CAGR during the forecast period.

Buy Complete Report of Microtome Market Study at: https://www.theinsightpartners.com/buy/TIPRE00006522/

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

We are committed to provide highest quality research and consulting services to our customers. We help our clients understand the key market trends, identify opportunities, and make informed decisions with our market research offerings at an affordable cost.

Contact Us

Contact Person: Sameer Joshi

Phone: +1-646-491-9876

E-mail: sam@theinsightpartners.com

Back to news